Trial Profile
A STUDY TO INVESTIGATE THE EFFECT OF PANCRELIPASE DELAYED RELEASE CAPSULES ON MALDIGESTION IN PATIENTS WITH EXOCRINE PANCREATIC INSUFFICIENCY DUE TO CHRONIC PANCREATITIS AND PANCREATECTOMY
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 18 Jul 2018
Price :
$35
*
At a glance
- Drugs Pancrelipase (Primary)
- Indications Exocrine pancreatic insufficiency; Pancreatitis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Solvay
- 05 Jun 2018 Results assessing coefficient of fat absorption from S245-3-124 & S245-5-009 trials (n=116) presented at the Digestive Disease Week 2018
- 22 Jan 2015 New trial record